Boston Scientific Corp. and its subsidiary, Guidant, will pay $30 million to settle allegations that Guidant knowingly sold defective heart devices that were implanted in Medicare patients between 2002 and 2005.
In a civil action filed by the United States Department of Justice on January 27, 2011, the DOJ alleged that Guidant knowingly sold defective implantable defibrillators. These devices are surgically implanted into patients’ chests to ...
continue reading...
On a day that Merck announced its intent to lay off 8,500 employees, a federal judge approved a settlement in which Merck agreed to pay $688 million for allegedly defrauding shareholders.
Merck agreed to pay this amount in order to resolve a class action lawsuit in which it was alleged that the company withheld adverse results of a clinical trial of Vytorin and Zetia, two anti-cholesterol drugs. The purpose of ...
continue reading...According to Boston.com, a $20.6 million verdict has been upheld in the death of a woman by an inflatable pool slide, sold by the popular children’s store Toys “R” Us.
The Supreme Judicial Court of Massachusetts ruled in a unanimous opinion, that it could “discern no error” in the lower court’s ruling that affirmed the verdict. The Court said that there was sufficient evidence to support the jury’s findings of negligence, breach of warranty, and gross negligence, and concluded that ...
continue reading...
A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports.
At the conclusion of a non-jury trial, U.S. District Judge Janet Bond Arterton in New Haven, Conn., ruled that Ethicon infringed three U.S. patents for ultrasonic surgical instruments owned by Covidien.
Ethicon recently suffered another multi-million setback, in the form of an $11.1 million jury ...
continue reading...
Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has pleaded guilty to drug safety violations. According to a story in the New York Times, the company will pay $500 million in fines over allegations that it sold subpar drugs.
Company officials also allegedly made false statements to the U.S. Food and Drug Administration about manufacturing practices at two factories in India.
Daiichi Sankyo has faced other allegations recently concerning its medications.
Two ...
continue reading...
According to British newspaper the Mansfield and Ashfield Chad, a 26-year-old man left disabled from birth because of a traumatic brain injury has successfully sued for damages.
Although the amount is undisclosed, the story says the equivalent of millions of dollars have been awarded in similar cases.
The man’s mother filed the lawsuit on his behalf. According to the story, he was deprived of oxygen during his birth at King’s Mill Hospital ...
continue reading...
